Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Expression data from age-dichotomized ER+, N0 breast tumors
PubMed Full text in PMC Similar studies Analyze with GEO2R
Expression data of MCF7 cells following short-term E deprivation, ER-alpha siRNA knockdown and oxidant treatments
Expression data from age-dichotomized ER+ breast tumors
The NFκB pathway promotes endocrine therapy tolerance through activation of integrated stress response in ER positive breast cancer
PubMed Full text in PMC Similar studies SRA Run Selector
Expression data from MCF7 and BT474 cell lines after long term estrogen deprivation culture
Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
Tamoxifen-resistant human breast cancer cell lines
Estrogen-regulated genes predict survival in estrogen receptor and/or progesterone receptor-positive breast cancers
PubMed Similar studies Analyze with GEO2R
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor positive breast cancer
XBP1 confers estrogen independence and antiestrogen resistance in breast cancer cell lines
X-Box binding protein overexpression effect on breast cancer cell line
PubMed Similar studies GEO Profiles Analyze DataSet
Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. [ChIP-seq]
PubMed Full text in PMC Similar studies
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. [cell models RNA-seq]
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. [tumor samples RNA-seq]
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer [array]
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer [ChIP-Seq]
Estrogen and progesterone receptor dynamics in patient-derived luminal breast cancer xenografts
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on